We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Fevertree Drinks Plc | FEVR | London | Ordinary Share |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
675.50 | 675.50 | 695.00 | 687.00 |
Industry Sector |
---|
BEVERAGES |
Announcement Date | Type | Currency | Dividend Amount | Ex Date | Record Date | Payment Date |
---|---|---|---|---|---|---|
12/09/2024 | Interim | GBP | 0.0585 | 26/09/2024 | 27/09/2024 | 18/10/2024 |
26/03/2024 | Final | GBP | 0.109 | 16/05/2024 | 17/05/2024 | 21/06/2024 |
12/09/2023 | Interim | GBP | 0.0574 | 28/09/2023 | 29/09/2023 | 20/10/2023 |
22/03/2023 | Final | GBP | 0.1068 | 20/04/2023 | 21/04/2023 | 02/06/2023 |
13/09/2022 | Interim | GBP | 0.0563 | 29/09/2022 | 30/09/2022 | 21/10/2022 |
16/03/2022 | Final | GBP | 0.1047 | 07/04/2022 | 08/04/2022 | 27/05/2022 |
16/03/2022 | Special | GBP | 0.429 | 07/04/2022 | 08/04/2022 | 27/05/2022 |
15/09/2021 | Interim | GBP | 0.0552 | 30/09/2021 | 01/10/2021 | 22/10/2021 |
18/03/2021 | Final | GBP | 0.1027 | 08/04/2021 | 09/04/2021 | 28/05/2021 |
08/09/2020 | Interim | GBP | 0.0541 | 24/09/2020 | 25/09/2020 | 16/10/2020 |
22/04/2020 | Final | GBP | 0.0988 | 14/05/2020 | 15/05/2020 | 12/06/2020 |
Top Posts |
---|
Posted at 13/9/2024 08:19 by masurenguy Fever-Tree commits to London listing as shares hit 8 year lowA dismal start to the British summer takes shine off sales at the mixers group Announcing first-half results, the company lowered expectations for annual revenue growth to 4-5%, from a previously guided 10% in March. Fever-Tree also cut its 2023 annual forecast at the same stage last year by 15% and took a £3.3m hit on its US division from a production issue. The update sent shares in Fever-Tree down by 100p, or 11.6%, to an eight-year low at 762½p on the Aim index. The stock remains well below the highs of almost £40 achieved before the pandemic and cost-of-living crisis shuttered pubs and wallets. In the first half, Fever-Tree reported a 2% increase in revenue to £170.6m, with the UK down 6% to £50.9 million and Europe down 12% to £44.5m. The US was up 7 per cent to £60.3m, and revenues for the rest of the world were 57% higher at £14.9m. Underlying earnings in the first half jumped by 79% to £18.2m, and the company declared a dividend up 2% at 5.85p per share. Warrillow, 49, who remains chief executive, said that the situation had improved strongly “as summer belatedly arrived. Whilst the first half was challenging, we are controlling the controllables. We’re optimistic of an acceleration of growth across the second half of the year and have seen a much more positive trading performance in July and August.” “Fevertree is doing the right things, gaining share and delivering on gross margin recovery, in a difficult market,” Investec analyst Matthew Webb said. Complete article: No position but onto my watchlist. |
Posted at 13/9/2024 06:25 by laurence llewelyn binliner An interesting watch, I am looking to replace BVIC now bought out by Carlsberg, could FEVR become the next target for a bigger player and more MnA..? 10% off yesterday and could continue south with the revised outlook..? |
Posted at 12/9/2024 07:50 by eezymunny Look at all the competition now:It used to be schweppes massive dominance which was crushed by FEVR. All down hill from here in the UK possibly.... |
Posted at 20/8/2024 09:15 by philanderer Fever-Tree can fizz again, says Deutsche BankPremium mixer business Fever-Tree (FEVR) is trading at an ‘attractive valuation’ despite the challenging backdrop, says Deutsche Bank. Analyst Deirdre Mullaney retained her ‘buy’ recommendation but reduced the target price from £16 to £14.50 on the stock, which rose 2% to 913p on Monday after a full-year preview. The shares have tumbled 9% year-to-date. Despite the downbeat sentiment towards the business, Mullaney said that she ‘continues to believe Fever-Tree is well positioned to capitalise on the long-term premium mixer opportunity given its strong brand equity and large white space opportunity overseas’. Falling costs, new supply agreements and supply chain improvements will allow ‘strong margin recovery than consensus expects in outer years’. However, Mullaney said that near-term the ‘stock will struggle given the challenging market backdrop’, leading her to revise down full-year 2024 and 2025 expectations that reflect a ‘negative weather impact over the summer and weak global spirits market’. The shares trade on 23.1 times price to earnings for 2025 which Mullaney said ‘is an attractive valuation given the long-term growth potential’. Citywire.com |
Posted at 25/7/2024 08:31 by bulltradept US recession looming, FEVR might have a few issues going forward.. |
Posted at 10/6/2024 23:42 by growthpotential Need to see some growth in ROW including Australia. Got the in laws coming over next weekend and have just got some ginger ales, raspberry lemonade and Italian blood orange soda in from the Fever-Tree range. Also spoke to someone else at the supermarket till and she says the FEVR drinks are great |
Posted at 30/5/2024 08:14 by apad I first bought FEVR in 2014 and have increased every year in the 10 years since. Trimmed a few times and my net cost is about half the current price. Divis ignored.My current focus is entirely on the US where they employed americans to manage the company, rather than running it from the UK. As a result they are rolling out steadily and sensibly through States as if they are different countries, creating appropriate mixers and linking with spirits companies. They are doing better at surviving the difficult markets in consumer products than a lot of companies with different products and the brand is difficult to attack. Brands have marketing value that is not represented in the balance sheet but shouldn't be ignored. It's my second biggest holding so I won't be increasing, but I think now is a good entry opportunity. Negative broker comments and a difficult world is the right time to buy solid companies with a lead over the opposition. Especially when they are moving through a country much richer than the ROW. apad |
Posted at 27/1/2024 21:08 by apad In these times of highly fluctuating costs, how many years of revenue buys the company is a good metric.FEVR is about 3.5 years. Given the potential for growth this is not so expensive. Amusingly Bioventix is 19 years 😊 apad |
Posted at 16/1/2024 14:14 by philanderer Liberum upgrades Fevertree on recovery prospectsLiberum has upgraded premium mixer maker Fevertree (FEVR) as a trough in margins indicates a recovery in this year and next. Analyst Anubhav Malhotra upgraded his recommendation from ‘hold’ to ‘buy’ and increased the target price from £12.00 to £13.00 on the stock, which was trading at £9.98 on Monday. Malhotra said the company’s strategy ‘has been focused on market share gains against a backdrop of significant input cost inflation over the last two years’. Margins have ‘troughed̵ ‘We see scope for a greater recovery in 2024 and 2025 than consensus expects and therefore move to ‘buy’ ‘Despite the [fact] that ‘bad news’ might not be over, the valuation at 17x 12 months forward consensus embedded value/Ebitda and 28x price/earnings – 40-50% below historic average – looks reasonable.’ Mahotra said that for investors ‘wanting to build a position, now is the time considering the low average daily volume of 265,000’. citywire.com |
Posted at 30/9/2019 21:36 by trying2getrichquick Fevertree DrinksMarket Cap - UK£2.8b Last Updated - 2019/09/29 22:01 UTC Executive Summary Fevertree Drinks Plc, together with its subsidiaries, develops and supplies premium mixer drinks in the United Kingdom, the United States, Europe, and internationally. Snowflake Fundamentals Flawless balance sheet with solid track record. Share Price & News How has Fevertree Drinks's share price performed over time and what events caused price changes? Latest Share Price and Events Market Performance 7 Day Return 0.6% FEVR 2.1% GB Beverage 0.2% GB Market 1 Year Return -32.9% FEVR 15.7% GB Beverage -1.8% GB Market Return vs Industry: FEVR underperformed the UK Beverage industry which returned 15.7% over the past year. Return vs Market: FEVR underperformed the UK Market which returned -1.8% over the past year. Share holder returns FEVR Industry Market 7 Day 0.6% 2.1% 0.2% 30 Day 7.1% -4.7% 3.3% 90 Day 4.8% -3.0% -0.4% 1 Year -32.5%-32.9% 18.9%15.7% 2.8%-1.8% 3 Year 153.1%149.6% 62.1%50.3% 21.3%6.8% 5 Year n/a 112.2%85.4% 36.2%7.3% Price Volatility Vs. Market Valuation Is Fevertree Drinks undervalued based on future cash flows and its price relative to the stock market? Analysis Checks 0/6 44.15x Price to Earnings (PE) ratio Intrinsic Value Based on Future Cash Flows 25.8%Overvalued Current PriceUK£24.21F Undervalued: FEVR (£24.21) is trading above our estimate of fair value (£19.25) Significantly Undervalued: FEVR is trading above our estimate of fair value. Price Based on Earnings }}}0x10x20x30x40x50x PE Ratio company 44.1x industry 25.2x market 16x PE vs Industry: FEVR is poor value based on its PE Ratio (44.1x) compared to the Beverage industry average (25.2x). PE vs Market: FEVR is poor value based on its PE Ratio (44.1x) compared to the UK market (16x). Price Based on Expected Growth }0x1x2x3x4x PEG Ratio company 4.2x Low PEG Ratio: FEVR is poor value based on its PEG Ratio (4.2x) Price Based on Value of Assets }}}0x5x10x15x20x PB Ratio company 14x industry 3.6x market 1.5x PB vs Industry: FEVR is overvalued based on its PB Ratio (14x) compared to the GB Beverage industry average (3.6x). Next Steps Explore potentially undervalued companies in the Food, Beverage & Tobacco industry. Future Growth How is Fevertree Drinks expected to perform in the next 1 to 3 years based on estimates from 11 analysts? Analysis Checks 3/6 10.5% Forecasted annual earnings growth Earnings and Revenue Growth Estimates GBPRevenueCash FlowEarnings Growth Rates201720182019202 Future Annual Growth Analysis company10.5%industry market12.5% forecast annual earnings growth company12.3%industry market4.1% forecast annual revenue growth Earnings vs Savings Rate: FEVR's forecast earnings growth (10.5% per year) is above the savings rate (1.2%). Earnings vs Market: FEVR's earnings (10.5% per year) are forecast to grow slower than the UK market (12.5% per year). High Growth Earnings: FEVR's earnings are forecast to grow, but not significantly. Revenue vs Market: FEVR's revenue (12.3% per year) is forecast to grow faster than the UK market (4.1% per year). High Growth Revenue: FEVR's revenue (12.3% per year) is forecast to grow slower than 20% per year. Earnings per Share Growth Estimates GBP 20172018201920202021 Historical Range of past estimates Analyst's estimate Range of estimates Future Return on Equity }}0%10%20%30%40% Future ROE (3yrs) company 26.4% industry 18.1% High Future ROE: FEVR's Return on Equity is forecast to be high in 3 years time (26.4%) Past Performance How has Fevertree Drinks performed over the past 5 years? Analysis Checks 5/6 48.6% Historical annual earnings growth Earnings and Revenue History GBPRevenueCash FlowEarningsOperatin Growth Rate2013201420152016 Past Earnings Growth Analysis company48.6%industry market13.4% past 5 years annual earnings growth company21.1%industry market6.8% last 1 year earnings growth Earnings Trend: FEVR's earnings have grown significantly by 48.6% per year over the past 5 years. Accelerating Growth: FEVR's earnings growth over the past year (21.1%) is below its 5-year average (48.6% per year). Earnings vs Industry: FEVR earnings growth over the past year (21.1%) exceeded the United Kingdom of Great Britain and Northern Ireland industry 4.6%. Return on Equity }}0%10%20%30%40% ROE company 31.7% industry 18.1% High ROE: FEVR's Return on Equity (31.7%) is considered high. Return on Assets }}0%2%4%6%8%10% ROA company 26.5% industry 8.5% ROA vs Industry: FEVR has a higher Return on Assets than the Beverage industry average last year. Return on Capital Employed }}0%10%20%30% ROCE last year 38.4% 3 years ago 27.6% ROCE Improving: FEVR has significantly improved its Return on Capital Employed over the past 3 years. Financial Health How is Fevertree Drinks's financial position? Analysis Checks 5/6 Financial Position Analysis GBP 20132014201520162017 GBPShort termLong termNet worth LiabilitiesAssets Short Term Liabilities: FEVR's short term assets (£189.9M) exceeds its short term liabilities (£36.7M) Long Term Liabilities: FEVR's short term assets (£189.9M) exceeds its long term liabilities (£1.5M) Debt to Equity History and Analysis GBPDebtNet worth (Equity)Cash 20132014201520162017 Debt Level: FEVR is debt free. Reducing Debt: FEVR currently has no debt however we can't compare to 5 years ago as we have no data for that period. Debt Coverage: FEVR has no debt, therefore it does not need to be covered by operating cash flow. Interest Coverage: FEVR has no debt, therefore coverage of interest payments is not a concern. Balance Sheet Assets Cash + Short termInvestmentsRecei Liabilities + Equity EquityDebtAccountsPa Inventory Level: FEVR has a low level of unsold assets or inventory. Debt Coverage by Assets: Insufficient data to determine if FEVR's debt is covered by short term assets. Dividend What is Fevertree Drinks's current dividend yield, its reliability and sustainability? Analysis Checks 0/6 0.80% Expected Dividend Yield Dividend Yield and Payments Analysis DPSFEVR DPSFEVR YieldBeverageMarket 20162017201820192020 2.1% 1.4% 0.1% 0.6% Notable Dividend: FEVR's dividend (0.6%%) isn’t notable compared to the bottom 25% of dividend payers in the UK market (1.97%%). High Dividend: FEVR's dividend (0.6%) is low compared to the top 25% of dividend payers in the UK market (5.47%). Stable Dividend: FEVR is not paying a notable dividend for the UK market, therefore no need to check if payments are stable. Growing Dividend: FEVR is not paying a notable dividend for the UK market, therefore no need to check if payments are increasing. Current Payout to Shareholders 28%Now Retained byFevertree Drin…Paid to you Dividend Coverage: FEVR is not paying a notable dividend for . Future Payout to Shareholders 30%+3 yrs Retained byFevertree Drin…Paid to you Future Dividend Coverage: No need to calculate the sustainability of FEVR's dividend in 3 years as they are not forecast to pay a notable one for the UK market. Management What is the CEO of Fevertree Drinks's salary, the management and board of directors tenure and is there insider trading? 3.3yrs Average board tenure CEO Tim Warrillow (44yo) 0yrs Tenure UK£3,981,000 Compensation Mr. Timothy Daniel Gray Warrillow, also known as Tim, is a Co-Founder, Chief Executive Officer and Executive Director at Fevertree Drinks Plc. Mr. Warrillow joined a London-based advertising and branding a ... CEO Compensation Analysis GBPTotal CompensationSalaryFe 20142015201620172018 Compensation vs. Market: Tim's total compensation ($USD4.90M) is about average for companies of similar size in the UK market ($USD2.26M). Compensation vs Earnings: Tim's compensation has increased by more than 20% in the past year. Board Age and Tenure 3.3yrs Average Tenure 55yo Average Age Experienced Board: FEVR's board of directors are considered experienced (3.3 years average tenure). Insider Trading SOLDBOUGHTSold by companiesSold by individualsBought by companiesBought by individuals0-3 months3-6 months6-9 months9-12 months Insider Buying: FEVR insiders have bought more shares than they have sold in the past 3 months. Recent Insider Transactions AIM:FEVR Recent Insider Transactions by Companies or IndividualsDate Value Name Entity Role Shares Max Price 16 Aug 19 BuyUK£43,320 Jeff Popkin Individual 2,000 UK£21.66 25 Jul 19 BuyUK£289,561 Kevin Havelock Individual 13,298 UK£21.99 07 Dec 18 BuyUK£67,843 Jeff Popkin Individual 2,933 UK£23.17 11 Oct 18 BuyUK£167,946 Kevin Havelock Individual 5,727 UK£29.55 Ownership Breakdown General PublicIndividual InsidersPrivate CompaniesInstitution Institutions Private Companies Individual Insiders General Public Management Team Charles Rolls (62yo) Co-Founder & Non-Executive Deputy Chairman Tenure: 0yrs Tim Warrillow (44yo) Co-Founder Tenure: 0yrs Compensation: UK£3.98m Andy Branchflower (40yo) Finance Director Tenure: 4.9yrs Compensation: UK£1.92m Saskia Stoop (35yo) Head of Marketing Tenure: 0yrs Claire Huntingford (38yo) Head of Supply Chain Tenure: 0yrs Charles Gibb Global Strategy Director & CEO of North American Tenure: 1.8yrs Oliver Winters Communications & IR Director Tenure: 0yrs Board Members Bill Ronald (63yo) Non-Executive Chairman Tenure: 6.3yrs Compensation: UK£125.00k Coline McConville (55yo) Independent Non-Executive Director Tenure: 4.8yrs Compensation: UK£58.00k Jeff Popkin (54yo) Independent Non Executive Director Tenure: 1.7yrs Compensation: UK£46.00k Kevin Havelock (61yo) Independent Non-executive Director Tenure: 1.7yrs Compensation: UK£46.00k Domenic De Lorenzo (55yo) Independent Non-Executive Director Tenure: 1.3yrs Compensation: UK£30.00k Charles Rolls (62yo) Co-Founder & Non-Executive Deputy Chairman Tenure: 0yrs Tim Warrillow (44yo) Co-Founder Tenure: 0yrs Compensation: UK£3.98m Andy Branchflower (40yo) Finance Director Tenure: 4.9yrs Compensation: UK£1.92m Company Information Fevertree Drinks Plc's company bio, employee growth, exchange listings and data sources Key Information Fevertree Drinks Plc logo Name: Fevertree Drinks Plc Ticker: FEVR Exchange: AIM Founded: 2013 Industry: Soft Drinks Sector: Food, Beverage & Tobacco Market Cap: UK£2.811b Shares outstanding: 116.13m Website: hxxps://www.fever-tr Fevertree Drinks Plc 186 -188 Shepherds Bush Road London Greater London W6 7NL United Kingdom Listings Ticker Exchange Primary Security Security Type Country Currency Listed on FEVR AIM (London Stock Exchange AIM Market) Yes Ordinary Shares GB GBP Nov 2014 FQVT.F OTCPK (Pink Sheets LLC) Yes Ordinary Shares US USD Nov 2014 FV8 DB (Deutsche Boerse AG) Yes Ordinary Shares DE EUR Nov 2014 Biography Fevertree Drinks Plc, together with its subsidiaries, develops and supplies premium mixer drinks in the United Kingdom, the United States, Europe, and internationally. The company’s products include Indian ... Company Analysis and Financial Data Status All financial data provided by Standard & Poor's Capital IQ.Data Last Updated (UTC time) Company Analysis 2019/09/29 22:01 End of Day Share Price 2019/09/27 00:00 Earnings 2019/06/30 Annual Earnings 2018/12/31 Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Credit: Simply Wall Street |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions